Brain Cancer Market Set for Strong Growth by 2035 – BIS Research

What Is Brain Cancer Treatment? 

Brain cancer treatment encompasses surgical resection, radiation, chemotherapy, targeted therapy, and immunotherapy. The field is now evolving to incorporate biomarker-driven precision medicine such as genetic marker-based therapies and immunotherapies offering the potential for better tumour-specific targeting and improved patient outcomes. 

Request sample report now on the Global Brain Cancer Market 

What Is the Market Outlook? 

• The market is dominated by North America, due to its advanced infrastructure, early diagnosis rates, and presence of major pharma players. 
• Regions covered include North America, Europe, Asia-Pacific, and Rest of World, with country-level breakdown for major players. 
• The lifecycle stage is transitioning away from traditional treatments toward genetically targeted solutions and immunotherapies  

How Fast Is the Market Growing? 

While exact figures are behind paywall, key growth drivers include: 

• Increasing global incidence of brain cancer 
• Technological advancements in molecular diagnostics and treatment modalities 
• Surge in precision medicine approaches 

Unlock Critical Insights with Surgical Procedure Database   

Discover BIS Research Surgical Procedure Volume Database – your key to real-world, country-level procedural insights across MedTech.      

How Will This Report Help You? 

Planning to Enter the Market? 

• Offers global and country-level epidemiological data – including the U.S., Canada, Germany, France, UK, China, Japan, India, etc. 

Analysing the Competitive Landscape? 

• Includes profiles of key players like Merck & Co., Novartis, Genentech, Orbus Therapeutics, VBL Therapeutics and DNAtrix  

Seeking R&D Insights? 

• Tracks innovations in biomarkers, immunotherapy, biologics approvals, and precision medicine pipelines 

Download the Full TOC and Report Sample         

What’s Driving Demand, Opportunities, and Barriers? 

Drivers: 

• Rising incidence of brain cancer 
• Technological advancements (targeted therapies, immunotherapy, precision diagnostics) 
• Emphasis on personalized medicine  

Restraints: 

• High costs associated with new therapies 
• Regulatory complexities 
• Infrastructure limitations in emerging markets  

Opportunities: 

• Pipeline for personalized vaccines and oncolytic therapies 
• Expansion of immunotherapy and biomarker-based treatment strategies 

Key Players 

• Merck & Co., Inc. 

• Novartis AG 

• Genentech 

• Orbus Therapeutics 

• VBL Therapeutics 

• DNAtrix 

Strategic Moves Shaping the Future 

• Shift toward precision-medicine-based therapies 
• Increased R&D investment in biomarker-initiated immunotherapies and biologics 
• Alliances, partnerships, and licensing deals among big pharma leveraging targeted approaches 

Download the complete TOC now! 

Case Study 

A U.S. cancer center initiated a personalized neoantigen vaccine in a phase II trial for glioblastoma. Patients demonstrated improved immune response and stabilization of tumour growth compared to historical controls 

Schedule a Call with Industry Experts  

Related Reports from BIS Research  

Cancer Cachexia Market 

Testicular Cancer Market 

Non-Metastatic Prostate Cancer Market 

About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    

Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on youtube@ https://www.youtube.com/@BISResearchInc